Castleman disease and associated autoimmune disease

Theresa W. Muskardina; Bruce A. Peterson; Jerry A. Molitor

doi:10.1097/BOR.0b013e32834db525

Castleman disease and associated autoimmune disease

Theresa W. Muskardina, Bruce A. Peterson, Jerry A. Molitor

Research output: Contribution to journal › Review article › peer-review

58 Scopus citations

Abstract

Advances in understanding of pathogenic cell types and cytokines in Castleman disease have allowed the development of targeted therapies successful in the treatment of both Castleman disease and associated autoimmune disease.

Original language	English (US)
Pages (from-to)	76-83
Number of pages	8
Journal	Current Opinion in Rheumatology
Volume	24
Issue number	1
DOIs	https://doi.org/10.1097/BOR.0b013e32834db525
State	Published - Jan 2012

Keywords

B-lymphocyte
Castleman disease
Innate immunity
Interferon
Interleukin-6
Plasmacytoid dendritic cell

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1097/BOR.0b013e32834db525

Find It

Find It at U of M Libraries

Cite this

@article{a07931823a0945fb8c2a5624b477cb78,

title = "Castleman disease and associated autoimmune disease",

abstract = "Advances in understanding of pathogenic cell types and cytokines in Castleman disease have allowed the development of targeted therapies successful in the treatment of both Castleman disease and associated autoimmune disease.",

keywords = "B-lymphocyte, Castleman disease, Innate immunity, Interferon, Interleukin-6, Plasmacytoid dendritic cell",

author = "Muskardina, \{Theresa W.\} and Peterson, \{Bruce A.\} and Molitor, \{Jerry A.\}",

year = "2012",

month = jan,

doi = "10.1097/BOR.0b013e32834db525",

language = "English (US)",

volume = "24",

pages = "76--83",

journal = "Current Opinion in Rheumatology",

issn = "1040-8711",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Castleman disease and associated autoimmune disease

AU - Muskardina, Theresa W.

AU - Peterson, Bruce A.

AU - Molitor, Jerry A.

PY - 2012/1

Y1 - 2012/1

N2 - Advances in understanding of pathogenic cell types and cytokines in Castleman disease have allowed the development of targeted therapies successful in the treatment of both Castleman disease and associated autoimmune disease.

AB - Advances in understanding of pathogenic cell types and cytokines in Castleman disease have allowed the development of targeted therapies successful in the treatment of both Castleman disease and associated autoimmune disease.

KW - B-lymphocyte

KW - Castleman disease

KW - Innate immunity

KW - Interferon

KW - Interleukin-6

KW - Plasmacytoid dendritic cell

UR - http://www.scopus.com/inward/record.url?scp=82955233372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955233372&partnerID=8YFLogxK

U2 - 10.1097/BOR.0b013e32834db525

DO - 10.1097/BOR.0b013e32834db525

M3 - Review article

C2 - 22157415

AN - SCOPUS:82955233372

SN - 1040-8711

VL - 24

SP - 76

EP - 83

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

IS - 1

ER -

Castleman disease and associated autoimmune disease

Abstract

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this